Agent-based modeling for personalized prediction of an experimental immune response to immunotherapeutic antibodies.

Targeting immune checkpoint pathways to evoke an immune response against tumors has revolutionized clinical oncology over the last decade. Antibodies that block the PD-1/PD-L1 pathway have demonstrated effective antitumor activity in cancer patients and are approved for treatment of several differen...

Full description

Saved in:
Bibliographic Details
Main Authors: Omri Matalon, Andrea Perissinotto, Kuti Baruch, Shai Braiman, Anat Geiger Maor, Eti Yoles, Ella Wilczynski, Uri Nevo, Avner Priel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0324618
Tags: Add Tag
No Tags, Be the first to tag this record!